Sunshine Heart: Cutting Jobs

Chris Newmarker

September 9, 2016

1 Min Read
MDDI logo in a gray background | MDDI

Sunshine Heart (Eden Prairie, MN) cut its workforce by nearly a third, to 38, in 2015 as it twice had to halt the pivotal U.S. trial for its C-Pulse heart failure device, according to EP Vantage

Sunshine Heart's implantable device is meant to assist the pumping of heart failure patients' hearts without having to come in contact with blood. It uses a balloon counter-pulsation technology, an extra aortic cuff implanted above the aortic valve. Leads exit the skin and are connected to an external driver housed in a bag that can be carried around. EP Vantage, though, notes that there was investor disappointment over the need to implant the device through a sternotomy, not exactly as minimally invasive as the procedure was thought to be. 

Continue >>

[Image courtesy of Sunshine Heart]

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like